The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions
Other
OA: closed
CC0
⤵ 7 in-corpus citations
AI-generated summary
This study identified the oncofetal protein IMP3 as a promising biomarker for differentiating premalignant atypical endometriotic lesions from benign ones.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To determine whether the oncofetal protein IMP3 is detectable in endometriomas with or without histological atypia and whether IMP3 staining can be used as a triage tool to identify foci of atypical endometriosis in doubtful cases.
DESIGN: Retrospective study.
SETTING: Academic department and referral center for endometriosis.
PATIENT(S): A consecutive series of 516 women who underwent excision of 874 endometriomas.
INTERVENTION(S): Histological review by three expert pathologists and immunohistochemical staining for IMP3.
MAIN OUTCOME MEASURE(S): Test performance of IMP3 immunohistochemistry versus first-round histology.
RESULT(S): The prevalence of atypical endometriosis was 1.7% (95% confidence interval [CI], 0.9%-3.3%) based on the number of women and 1.0% (95% CI, 0.5%-1.9%) based on the number of cysts. Three cases of atypical endometriosis were identified at first-round histological examination. Immunohistochemistry detected seven of the eight cases diagnosed as preneoplastic atypia at second-round histology and one case diagnosed as reactive atypia at second-round histology. The sensitivity of first-round histology was 33.3%, compared with 88.9% of IMP3 immunohistochemistry.
CONCLUSION(S): Immunohistochemical staining for IMP3 expression is a simple, inexpensive, and sensitive test that can be used in routine clinical practice as a triage tool to discriminate between cytological/structural atypia and confounding benign conditions.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (41)
- A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes via openalex
- An Italian association study and meta-analysis with previous GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified susceptibility loci for endometriosis via openalex
- Arias-Stella reaction as a diagnostic pitfall in a bladder biopsy with endometriosis: case report and review of the pseudoneoplastic bladder lesions via openalex
- ARID1A mutations in endometriosis-associated ovarian carcinomas via openalex
- Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence via openalex
- Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer via openalex
- Clear cell adenocarcinoma of the ovary arising in atypical endometriosis: a report of eight cases via openalex
- Endometriosis and ovarian cancer via openalex
- Endometriosis and ovarian cancer via openalex
- Genome-wide association meta-analysis identifies new endometriosis risk loci via openalex
- Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis via openalex
- Histologic transformation of benign endometriosis to early epithelial ovarian cancer via openalex
- Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis via openalex
- Insights into Assessing the Genetics of Endometriosis via openalex
- Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis via openalex
- Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities via openalex
- Ovarian atypical endometriosis: its close association with malignant epithelial tumours via openalex
- Ovarian cancer in endometriosis: epidemiology, natural history, and clinical diagnosis via openalex
- Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype via openalex
- Ovarian endometriosis showing decidual change and Arias-Stella reaction with biotin-containing intranuclear inclusions via openalex
- Ovarian tumors associated with atypical endometriosis via openalex
- Pathology of endometriosis via openalex
- Prognostic importance of hyperplasia and atypia in endometriosis via openalex
- Site of origin of epithelial ovarian cancer: the endometriosis connection via openalex
- The endometriosis-ovarian cancer connection: the case against preventive surgery via openalex
- The relationship of endometriosis and ovarian malignancy: a review via openalex
- W2019601632 via openalex
- W2002530816 via openalex
- W2121741947 via openalex
- W2125681453 via openalex
- W1989129418 via openalex
- W1984240217 via openalex
- W2132229544 via openalex
- W1971946120 via openalex
- W2317337384 via openalex
- W6601256010 via openalex
- W2040588648 via openalex
- W6606444624 via openalex
- W2020582501 via openalex
- W2091205264 via openalex
- W2094762373 via openalex
Cited by (7)
- Atypical Endometriosis: A Comprehensive Systematic Review of Pathological Patterns and Diagnostic Challenges 2024
- Safety of in-vitro fertilization in women with endometriosis 2021
- Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated? 2018
- Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care 2017
- Endometriosis and Cancer: Is There an Association? 2015
- Ovarian endometrioma: what the patient needs 2014
- Endometriosis: pathogenesis and treatment 2013
Source provenance
- europepmc
- last seen: 2026-11-16T06:11:45.710462+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:11:40.903767+00:00
- unpaywall
- last seen: 2026-08-14T06:25:32.811723+00:00
License: CC0
· commercial use OK